Advertisement
Radiation oncology expert Stephen Hahn

Dr. Stephen Hahn Nominated to Head FDA

0
Hahn is chief medical executive of The University of Texas MD Anderson Cancer Center in Houston
Average-risk adults between the ages of 50 and 75 years should be screened for colorectal cancer

CRC Screening Recommended for Average-Risk Adults Age 50 to 75

0
CRC screening test should be selected based on discussion of benefits, harms, costs with patients
Seriously ill Medicare enrollees experience considerable financial distress

Seriously Ill Medicare Beneficiaries Face Financial Hardship

0
Majority of respondents rely on help from family and friends, at considerable cost
Ground beef tainted with Salmonella has led to 10 known infections across six states

CDC: 1 Dead, 8 Hospitalized in Salmonella Outbreak Tied to Ground Beef

0
States affected include Colorado, California, Kansas, Iowa, Oklahoma, and Texas
One in three young adults receive medication for opioid use disorder in the 12 months after surviving an overdose

One in Three Young Adults Get Meds for Opioid Use Disorder After Overdose

0
Type of medication for opioid use disorder received appears to be associated with age
Intensive lowering of ambulatory blood pressure in older patients with hypertension reduced accumulation of small vessel disease in the white matter of the brain

Intensive BP Control in Elderly With HTN May Aid Brain Health

0
Authors say benefit in functional outcomes might be seen with longer follow-up
The Coronary Calcium Score may be a useful tool in cardiovascular risk assessment among female patients with rheumatoid arthritis

Coronary Calcium Score May ID CV Risk in Rheumatoid Arthritis

0
More active inflammation, high ApoB/ApoA1 ratio, and homocysteine tied to coronary calcium risk
Individuals with type 2 diabetes (T2D) are at higher risk for sustaining an incident vertebral fracture compared with individuals without T2D

Type 2 Diabetes Linked to Higher Risk for Vertebral Fractures

0
Patients with both T2DM, previous vertebral fracture have twofold risk for incident nonvertebral fracture
For patients with cystic fibrosis with Phe508del-minimal function genotypes

Elexacaftor-Tezacaftor-Ivacaftor Efficacious for Cystic Fibrosis

0
Percentage of FEV1 higher at four weeks and through 24 weeks with treatment versus placebo
Survivors of chronic lymphocytic leukemia have an increased risk for second primary malignancy

Risk for Second Primary Malignancy Up in CLL Survivors

0
SPM risk higher for men and nonwhites, after chemotherapy, for recent years of diagnosis, for advanced age